Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis
- 1 October 2010
- journal article
- clinical trial
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 69 (10) , 1842-1844
Abstract
Objective To study the influence of tumour necrosis factor (TNF) antagonists on spermatogenesis in a cohort of patients with spondyloarthritis (SpA). Patients and methods Semen samples of 26 patients with SpA were analysed according to WHO 1999 guidelines with and without TNF blocking agents (infliximab, etanercept or adalimumab). Results were compared with semen samples of 102 healthy volunteers. Results Sperm abnormalities were found in 10/11 patients without anti-TNF therapy. The sperm of these 11 patients had significantly poorer motility (p=0.001) and vitality (p=0.001) than found in 15 patients tested during longstanding anti-TNF therapy, but sperm concentration and morphology were similar in the two groups. There was no significant difference of sperm quality between healthy controls and anti-TNF treated patients with SpA. Notably, sperm abnormalities were also found in 102 healthy controls. Conclusion Sperm abnormalities are a common finding in healthy men, they are more pronounced in patients with active SpA. The sperm quality of patients with SpA with inactive disease receiving long-term TNF inhibition is comparable to that in healthy controls. The data support continuation of anti-TNF treatment when fatherhood is planned.Keywords
This publication has 13 references indexed in Scilit:
- World Health Organization reference values for human semen characteristics*‡Human Reproduction Update, 2009
- Asthenoazoospermia in patients receiving anti-tumour necrosis factor α agentsAnnals of the Rheumatic Diseases, 2005
- Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro modelFertility and Sterility, 2005
- Infliximab and Semen Quality in Men With Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2005
- Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid ArthritisAmerican Journal of Gastroenterology, 2004
- Tumor necrosis factor-alpha (TNF-alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonistEuropean Journal of Endocrinology, 2004
- GONADAL AND ADRENAL SEX STEROIDS IN ANKYLOSING SPONDYLITISRheumatic Disease Clinics of North America, 2000
- Methotrexate and reproduction in men: Case report and recommendationsJournal of the American Academy of Dermatology, 1993
- The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of SpondylarthropathyArthritis & Rheumatism, 1991
- The evaluation of morphological characteristics of human spermatozoa according to stricter criteriaHuman Reproduction, 1990